Meyka Pro banner
H.G. Infra Engineering Limited

Stay Updated with the Latest H.G. Infra Engineering Limited HGINFRA.BO News in Real Time

Find HGINFRA.BO news now at Meyka AI. Stay informed with the latest H.G. Infra Engineering Limited stocks updates, including price news, market analysis, and expert insights.

HGINFRA.BOBSE
IndustrialsEngineering & Construction
496.05
6.10(1.21%)
Indian Market opens in 64h 51m
Air Canada Faces Crisis as FAA Fires Controllers Over LaGuardia Crash Negligence
📅 in about 4 hours

Air Canada Faces Crisis as FAA Fires Controllers Over LaGuardia Crash Negligence

FAA fires LaGuardia air traffic controllers who left early before deadly Air Canada crash. Two pilots killed in March 22 collision. Staffing crisis deepens.

Read more 12
IT Stocks Rally: NIFTY IT Jumps 3% as TCS Gains 3.6%, Infosys 2.8% on Salesforce Boost
📅 in about 2 hours

IT Stocks Rally: NIFTY IT Jumps 3% as TCS Gains 3.6%, Infosys 2.8% on Salesforce Boost

IT stocks staged a sharp rally on August 28, 2026, pushing the NIFTY IT index up around 3%. TCS shares gained 3.6%, while Infosys rose 2.8% as strong global technology cues lifted investor sentiment. The move came after strong results from Salesforce and Nvidia, which renewed optimism around software, AI and enterprise technology spending. The…

Read more 12
Six Flags Stock Drops 3.4% as X2 Coaster Closure Deepens Injury Crisis
📅 in about 1 hour

Six Flags Stock Drops 3.4% as X2 Coaster Closure Deepens Injury Crisis

Six Flags (SIX) stock falls 3.4% to $32.00 as X2 coaster closure and CNN investigation into brain injuries threaten revenue and legal exposure. Ride linked to 12+ hospitalizations since 2002.

Read more 12
Indian Stock Market Today: SENSEX Jumps 350 Points, NIFTY50 Above 24,150 as IT Stocks Rally
📅 in 19 minutes

Indian Stock Market Today: SENSEX Jumps 350 Points, NIFTY50 Above 24,150 as IT Stocks Rally

Indian stock market indices extended gains through Friday morning, August 28, 2026, led by a sharp IT sector rally. The Sensex climbed roughly 366 points, or 0.47%, to near 77,295. The Nifty50 pushed past 24,168, building on its early gains. Nifty IT rose over 1% as traders awaited Fed Chair Kevin Warsh’s Jackson Hole remarks….

Read more 12
Bank Holiday Today, August 28: Are Banks Closed for Raksha Bandhan? Check State-Wise List
📅 21 minutes ago

Bank Holiday Today, August 28: Are Banks Closed for Raksha Bandhan? Check State-Wise List

Bank holiday today, August 28, 2026, applies to 11 states and union territories for Raksha Bandhan. The RBI holiday calendar confirms closures across Gujarat, Rajasthan, Uttar Pradesh, and several other regions. Banks in Delhi, Maharashtra, West Bengal, Karnataka, and Tamil Nadu remain open as usual. Customers can still access digital services like UPI and net…

Read more 12
Mizuho Sues Radiant World in Singapore Court as Police Probe Widens
📅 1 hour ago

Mizuho Sues Radiant World in Singapore Court as Police Probe Widens

Singapore police raid Radiant World’s office investigating falsified documents. Mizuho Bank files court injunction against the iron ore trader on August 28 as five banks discover fake invoices.

Read more 12
Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2
📅 9 hours ago

Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2

Yash’s Toxic opens with Rs 101.10 crore net on Day 1, one of India’s biggest openers, but drops 84% on Day 2 to Rs 16.48 crore as mixed reviews and trolls emerge.

Read more 12
Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume
📅 9 hours ago

Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume

HYPEUSD rallied 3.2% to $85.08 on August 27 following Hyperliquid’s launch of tokenized stocks and AQAv2 buyback engine on August 26.

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 18 hours ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12

HGINFRA.BO News FAQ